Nutritional High Partners With District 11 to Launch ST IDES Blunts
TORONTO, Sept. 11, 2019 (GLOBE NEWSWIRE) — Nutritional High International Inc. (“Nutritional High” or the “Company“) (CSE: EAT, OTCQB: SPLIF) is pleased to announce a distribution relationship with District 11, a licensed, premium cannabis company, through its wholly owned subsidiary, Calyx Brands (“Calyx”).
Calyx will help launch and distribute the ST IDES brand of pre-rolled, tobacco-free blunts to its network of nearly 600 retailers throughout the State of California.
ST IDES premium blunts will initially be sold at select cannabis retailers in Los Angeles, Long Beach and Oakland/San Francisco. They are available in nitrogen-flushed, resealable, collector tin two-packs (1.5 grams) and five-packs (3.75 grams). Retailers will be provided with branded reusable wooden tips for consumers who prefer smoking through a filter. ST IDES blunts are 100% indoor flower—no stems, no seeds—rolled into tobacco-free hemp leaf paper, allowing for a slow, consistent burn.
According to Ganjapreneur,* cannabis pre-rolls and blunts accounted for approximately $985M in 2018 sales, or roughly 7.7% of the total legal market for the US and Canada. This reflects an increase from approximately 5% of total 2017 sales, according to BDS Analytics**.
“We’re honored to represent ST IDES’ entry into cannabis,” said Dakota Sullivan, CEO of Calyx Brands. “The ST IDES brand and heritage, strong packaging and presentation combined with a pure indoor flower, high-quality blunt product that packs a punch—will make ST IDES a long-term player in the fast-growing and rapidly diversifying pre-roll category.”
For more information, please visit Calyx Brands at Hall of Flowers, Booth B319, September 18 & 19, Sonoma County Fairgrounds, Santa Rosa, CA.
*Ganjapreneur, May 14, 2019 “Five Predictions for the Pre-Roll Sector of the Cannabis Industry”
**BDS Analytics, September, 2017 report: “Now We Know What Californians Are Smoking”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively with licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market through its wholly owned subsidiaries in California and Oregon, as well as Colorado where its FLÏ™ products are manufactured by a third-party licensed producer. In California, the Company distributes its products and products manufactured by other leading producers through its wholly owned distributor Calyx Brands Inc. and is entering the Nevada, Washington State and Canadian markets in the near future.
About St. Ides Blunts
ST IDES made its initial debut in the late ’80’s as a top-selling malt liquor. In the ’90’s, during the golden age of hip-hop, ST IDES became an icon of the streets. The signature ‘crooked I’ got its bold reputation from its groundbreaking partnerships with the forefathers of modern hip-hop including Biggie, Tupac, Cypress Hill, Snoop Dogg and Ice Cube. Three decades later, the ST IDES brand continues to inspire people to forge their own path and break down barriers.
For further information, please contact:
Chairman of the Board
Nutritional High International Inc.
Director, Investor Relations
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The statements relate to potential market expansion and the use of the proceeds of the Offering. Risks that may have an impact on the ability for these events to be achieved include completion of due diligence, negotiation of definitive agreements and receipt of applicable approvals. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act“), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. Some of the risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information expressed in this press release include, but are not limited to: obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, the uncertainty of existing protection from U.S. federal or other prosecution, regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, market and general economic conditions of the cannabis sector or otherwise.